<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Epigenetics</journal-id><journal-id journal-id-type="iso-abbrev">Clin Epigenetics</journal-id><journal-title-group><journal-title>Clinical Epigenetics</journal-title></journal-title-group><issn pub-type="ppub">1868-7075</issn><issn pub-type="epub">1868-7083</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5525256</article-id><article-id pub-id-type="publisher-id">374</article-id><article-id pub-id-type="doi">10.1186/s13148-017-0374-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT</italic> in elderly Chileans</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sanchez</surname><given-names>Hugo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hossain</surname><given-names>Mohammad B.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lera</surname><given-names>Lydia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hirsch</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Albala</surname><given-names>Cecilia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Uauy</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Broberg</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ronco</surname><given-names>Ana M.</given-names></name><address><phone>+56 2 229781430</phone><email>amronco@inta.uchile.cl</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Unidad de Nutrici&#x000f3;n P&#x000fa;blica, Instituto de Nutrici&#x000f3;n y Tecnolog&#x000ed;a de los Alimentos Doctor. Fernando Monckeberg Barros (INTA), </institution><institution>Universidad de Chile, </institution></institution-wrap>El L&#x000ed;bano 5524, Macul, Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution>Division of Occupational and Environmental Medicine, </institution><institution>Lund University, </institution></institution-wrap>Lund, Sweden </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution/><institution>Institutet of Environmental Medicine, Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Unidad de Nutrici&#x000f3;n Humana, Instituto de Nutrici&#x000f3;n y Tecnolog&#x000ed;a de los Alimentos Doctor Fernando Monckeberg Barros (INTA), </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>9</volume><elocation-id>74</elocation-id><history><date date-type="received"><day>11</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Changes in DNA methylation, one of the most studied epigenetic mechanisms, are considered an initial marker for early cancer detection. We evaluated how availability of dietary factors (folates and vitamin B12) involved in one-carbon metabolism may contribute to DNA methylation changes of cancer-related genes in human subjects.</p></sec><sec><title>Methods</title><p id="Par2">We studied, by pyrosequencing, the methylation of tumor suppressor gene <italic>p16</italic>, DNA repair genes <italic>MLH1</italic> and <italic>MGMT</italic>, and the repetitive element LINE-1 (as a surrogate for global DNA methylation), in blood of elderly individuals (<italic>n</italic>&#x000a0;=&#x000a0;249) who had been exposed to folic acid (FA) through FA-fortified wheat flour during the last 12&#x000a0;years.</p></sec><sec><title>Results</title><p id="Par3">We found that serum folate and to a lesser extent, vitamin B12 concentrations, were significantly correlated with DNA methylation of <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT</italic>, but not with <italic>LINE-1</italic>. High serum folate concentrations (&#x0003e;45.3&#x000a0;nmol/L) were present in 31.1% of the&#x000a0;participants. Although the methylated fraction of CpG sites in <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT</italic> was low (1.17&#x02013;3.8%), high folate concentrations were significantly associated with methylation at the 3rd tertile of specific CpG sites in all genes with OR between 1.97 and 4.17.</p></sec><sec><title>Conclusions</title><p id="Par4">This study shows that a public policy, like food fortification with FA that increases circulating serum folate levels, could affect methylation levels of specific genes linked to cancer risk. Our present results deserve additional studies to clarify the real impact of high FA levels for risk of cancer in a whole population chronically exposed to a fortified food such as wheat flour.</p></sec><sec><title>Trial registration</title><p id="Par5">
<ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com">ISRCTN 48153354</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com">ISRCTN 02694183</ext-link>
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Folates</kwd><kwd>DNA methylation</kwd><kwd>Tumor suppressor genes</kwd></kwd-group><funding-group><award-group><funding-source><institution>Fondo Nacional de Ciencia y Tecnolog&#x000ed;a (FONDECYT), Gobierno de Chile</institution></funding-source><award-id>1130188</award-id></award-group><award-group><funding-source><institution>Fondo Nacional de Ciencia y Tecnolog&#x000ed;a (FONDECYT), Gobierno de Chile</institution></funding-source><award-id>1070592</award-id><principal-award-recipient><name><surname>Uauy</surname><given-names>Ricardo</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>Swedish Council for Working Life and Social Research FORTE</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par16">Folates are hydrosoluble vitamins naturally present in foods. Folates are essential during pregnancy due to their role in prevention of neural tube defects and in many physiological functions, including cell proliferation and differentiation processes, DNA replication, angiogenesis, methylation reactions through the one-carbon metabolism, and antioxidant protection [<xref ref-type="bibr" rid="CR1">1</xref>]. Due to the essentiality of folates during pregnancy, several countries have implemented fortification programs with folic acid (FA), the oxidized synthetic compound used in dietary supplements and food fortification. Chile started the fortification program in 2000 with 220&#x000a0;&#x003bc;g of FA/100&#x000a0;g of wheat flour, which led to a 40% decrease in the prevalence of neural tube diseases (NTD) 6&#x000a0;years later [<xref ref-type="bibr" rid="CR2">2</xref>]. However, this public policy has increased folate consumption across the whole population, since bread is one of the most consumed foods in Chile [<xref ref-type="bibr" rid="CR3">3</xref>]. In previous work, we have detected that 30% of the elderly people register circulating levels of folates higher than 48&#x000a0;nmol/L [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], slightly higher than the upper physiological reference value of 45.3&#x000a0;nmol/L described for adults [<xref ref-type="bibr" rid="CR6">6</xref>]. Some years ago, it was suggested that FA flour fortification masked vitamin B12 (Vit B12) deficiency found in elderly people [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]; this evidence led to the health authorities to supplement elderly population with this vitamin [<xref ref-type="bibr" rid="CR7">7</xref>]. Vit B12 is required for one-carbon metabolism and plays a key role in maintaining central and peripheral nervous system function [<xref ref-type="bibr" rid="CR8">8</xref>]. Low Vit B12 status occurs more frequently in older adults, and its global deficit in this group ranges from 7 to 51% [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Low Vit B12 concentration combined with high serum folates has been associated with increased risk of anemia, cognitive impairment, and neuroconduction alterations in older adults [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par17">Several biological functions of folates and Vit B12 are related with their participation in the one-carbon cycle that produces methyl groups for various processes in the body, such as DNA methylation, one of the key epigenetic processes in vertebrates [<xref ref-type="bibr" rid="CR12">12</xref>]. Epigenetic regulation plays a critical role in normal growth and embryonic development by controlling the transcriptional activities of several genes [<xref ref-type="bibr" rid="CR13">13</xref>]. A growing number of epigenetic changes have been reported in the regulation of key genes involved in cancer and aging [<xref ref-type="bibr" rid="CR14">14</xref>]. DNA methylation changes seem to be an early event in tumorigenesis and have therefore been proposed as potential markers for early cancer detection [<xref ref-type="bibr" rid="CR15">15</xref>]. Accumulating evidence indicates that DNA methylation markers in the stool and blood samples would provide a minimally invasive tool for colorectal cancer screening [<xref ref-type="bibr" rid="CR16">16</xref>]. For this reason, an elevated intake of folates, mainly as FA, whose absorption in the gastrointestinal tract is not saturable, may lead to aberrant DNA methylation in cancer genes and may be not safe [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par18">The Long Interspersed Nuclear Element 1 (LINE-1) retrotransposable elements make up about 17% of human DNA, and the methylation status of <italic>LINE-1</italic> is often used as a proxy for global DNA methylation [<xref ref-type="bibr" rid="CR18">18</xref>]. The CpG sites in LINE-1 are usually heavily methylated and genome-wide loss of methylation from these sites has been regarded as a common epigenetic event in malignancy [<xref ref-type="bibr" rid="CR19">19</xref>]. The <italic>p16</italic> tumor suppressor gene is found altered in a wide range of human cancers like endometrial carcinoma, hepatic, gastric, and colorectal cancer [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>], and it has been suggested as a biomarker for colorectal cancer [<xref ref-type="bibr" rid="CR23">23</xref>]. It encodes a specific inhibitor of cyclin-dependent kinase 4 and 6 and plays a pivotal role in tumor suppressor networks through inducing cellular senescence that acts as a barrier to cellular transformation by oncogenic signals [<xref ref-type="bibr" rid="CR24">24</xref>]. Also, <italic>p16</italic> loses its expression mainly by the hypermethylation of its promoter [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Methylated <italic>p16</italic> gene in blood may serve as a potential biomarker for cancer progression and a prognostic factor for several types of cancer [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par19">
<italic>MLH1</italic> promoter methylation has been implicated in the development of gastric and colorectal cancer; detection of MLH1 methylation in non-neoplastic gastric epithelia may be useful for screening patients who may be at risk of developing gastric cancer [<xref ref-type="bibr" rid="CR25">25</xref>]. <italic>MLH1</italic> is an important component in the mismatch repair system [<xref ref-type="bibr" rid="CR26">26</xref>], and a recent review highlighted the importance of epigenetic inactivation of <italic>MLH1</italic> gene in colorectal cancer [<xref ref-type="bibr" rid="CR27">27</xref>]. Also, <italic>MGMT</italic> is crucial for genome stability. It repairs the naturally occurring mutagenic DNA lesion and prevents mismatch and errors during DNA replication and transcription. A meta-analysis involving 14 studies showed that the frequency of <italic>MGMT</italic> methylation was significantly higher in colorectal cancer than in normal tissues [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par20">We have considered the chance that the increased incidence of colon cancer observed in Chile in the last years may be related with a high intake of FA due to food fortification with FA [<xref ref-type="bibr" rid="CR29">29</xref>]. However, to date, there is no enough evidence to associate high FA consumption with cancer.</p><p id="Par21">This report is a cross-sectional study aimed at evaluating epigenetic effects of high folate serum concentrations along with low, normal, or high Vit B12 serum concentrations on cancer-related genes and repetitive DNA sequences. The study was conducted in an elderly population in Chile who has been exposed to FA through fortified wheat flour during the last 12&#x000a0;years. We hypothesized that subjects with higher circulating concentrations of folates had increased levels of methylation in the tumor suppressor genes, to contribute with additional evidence related to the association between FA supplementation and colon cancer.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Subjects</title><p id="Par22">We included elderly Chileans that were enrolled for a larger randomized controlled study in Santiago, Chile. The detail of the protocol was published previously [<xref ref-type="bibr" rid="CR30">30</xref>]. The elderly were apparently healthy, free living, and beneficiaries of a complementary feeding program for older people above 65&#x000a0;years (called PACAM) [<xref ref-type="bibr" rid="CR31">31</xref>]. Exclusion criteria were as follows: severe cognitive impairment (Mini-Mental State Examination score &#x0003c;19 points [<xref ref-type="bibr" rid="CR32">32</xref>]); diabetes type 2 (fasting glucose concentrations &#x02265;126&#x000a0;mg/dL, insulin, or use of other medications for diabetes), advanced renal impairment (creatinine clearance &#x02264;30&#x000a0;mg/mL); hypothyroidism (TSH concentration &#x02265;6&#x000a0;mIU/L); gastrointestinal surgery; alcohol abuse based on reported daily consumption; or a clinical history of stroke.</p><p id="Par23">Participants of the study had been exposed to FA through fortification of wheat flour during the last 12&#x000a0;years since Chile started the nation-wide fortification program in the year 2000. Blood samples were collected and stored for blood measurements and DNA extraction. Ethics committees at the Institute of Nutrition and Food Technology (INTA) of the University of Chile and the Ministry of Health (Government of Chile) approved the study. All participants provided full written informed consent before being enrolled in the study and approved a consent to publish results.</p></sec><sec id="Sec4"><title>Analyses in blood</title><p id="Par24">Serum concentrations of folates, Vit B12, methyl malonic acid (MMA), and holotranscobalamin (HoloTC) were measured. MMA and HoloTC were used as sensitive tests for early or mild vitamin B12 deficiency. Total homocysteine (tHcy) in plasma was used as an indirect indicator of folate, vitamin B12, and B6 deficiency. Serum Vit B12 and folate concentrations were assessed in duplicate with the use of the SimulTRAC_SNB radioassay kit (57Co/Folate125I; MP Diagnostics) (coefficient of variance (CV) 15&#x02013;20%) [<xref ref-type="bibr" rid="CR11">11</xref>]. Serum MMA was analyzed with the use of ultraperformance liquid-chromatography&#x02013;tandem mass spectrometry [<xref ref-type="bibr" rid="CR33">33</xref>](CV 5%). Serum HoloTC was determined with the Axis-Shield HoloTC ELISA (Axis-Shield Diagnostics Ltd.) (CV 10%), and plasma tHcy was determined by HPLC with a fluorescence detector (Agilent 1200; Agilent) (CV 10&#x02013;15%).</p><p id="Par25">All serum and plasma markers were measured at the Department of Agriculture, Agricultural Research Services, Western Human Nutrition Research Center, Davis, CA, USA.</p></sec><sec id="Sec5"><title>DNA isolation and methylation analysis</title><p id="Par26">DNA was isolated from whole blood by DNeasy Blood &#x00026; Tissue kit (Qiagen) and quantified by Qubit dsDNA BR kit (Life Technologies) by the NanoQuant Infinite M200Pro (Tecan). DNA integrity was checked by agarose gels stained by ethidium bromide. Four hundred nanograms of DNA (20&#x000a0;ng/&#x003bc;L) was bisulfite-treated using EZ DNA Methylation kit (Zymo Research, catalog number D5008). Bisulfite treatment converts unmethylated cytosine into uracil residues, leaving the methylated cytosine unchanged. The bisulfite-treated DNA was stored at &#x02212;20&#x000a0;&#x000b0;C until used in PCR. We verified bisulfite conversion using non-CpG cytosine residues as built-in controls, and complete conversion of cytosine at a non-CpG site indicated successful bisulfite conversion.</p><p id="Par27">We studied, by pyrosequencing, the methylation of tumor suppressor genes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).&#x000a0;PCR and pyrosequencing: bisulfite-treated DNA (0.6&#x000a0;&#x003bc;L) was used in a 15-&#x003bc;L PCR reaction using the Pyromark PCR kit (Qiagen). One of the PCR primers was biotinylated. The PCR product was purified using Streptavidin Sepharose High Performance beads (Amersham Biosciences, Uppsala, Sweden). The Sepharose beads containing immobilized PCR products were purified, washed, and denatured with 0.2&#x000a0;M NaOH and washed again using a vacuum prep tool (Pyrosequencing Inc., Westborough, MA, USA). Twelve microliters of the pyrosequencing primer (0.3&#x000a0;&#x003bc;mol/L) was annealed to the purified single-stranded PCR product, and pyrosequencing was done using the PSQ HS96 Pyrosequencing System (Qiagen).<fig id="Fig1"><label>Fig. 1</label><caption><p>Pyrosequencing amplicons of <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT</italic> relative to known landmarks, including transcription start sites (TSS)</p></caption><graphic xlink:href="13148_2017_374_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par28">Commercially available assays (Qiagen) were used to measure the methylation of <italic>LINE-1</italic> (four CpG sites between 305 and 331&#x000a0;bp, GenBank accession no. X58075), <italic>p16</italic> (seven CpG sites between +148 and +174&#x000a0;bp around the transcription start site in exon 1; L27211), and <italic>MLH1</italic> (4 CpG sites between &#x02212;209 to &#x02212;188&#x000a0;bp from transcription start site; U07418) following the manufacturer&#x02019;s instruction [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. To determine the methylation level of <italic>MGMT</italic> promoter region, we developed an assay covering six CpG sites (&#x02212;219 to &#x02212;199&#x000a0;bp from transcription start site based on previous publications [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], ENSG00000170430). The assay was designed by PyroMark Assay Design 2.0 software (Qiagen). The sequences of forward, reverse, and sequencing primers are GGTTATTTGGTAAATTAAGGTATAGAGTT, biotin- AACTATCCCAACATATCC, and GTTGTAGGAGGATTAGG, respectively.</p><p id="Par29">We performed extensive quality control for the <italic>p16</italic> and <italic>MLH1</italic> assays as well as tested for amplification bias [<xref ref-type="bibr" rid="CR38">38</xref>] and found that both the assays were within recommended range for this type of bias [<xref ref-type="bibr" rid="CR35">35</xref>].</p></sec><sec id="Sec6"><title>Statistical analyses</title><p id="Par30">Continuous variables were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (standard deviation) and 95% confidence intervals (95% CI) or as median (p25&#x02013;p75) and&#x000a0;95% CI. Categorical variables were expressed as percentages and 95% CI. The difference between sexes was calculated by two-sample mean-comparison test, two-sample Wilcoxon rank-sum test or Pearson&#x02019;s Chi<sup>2</sup> test, depending on the kind of variables. Spearman correlations were calculated for blood concentrations of vitamins and metabolites and the methylation in specific CpG sites.</p><p id="Par31">We categorized vitamin B12 plasma levels as deficit (B12&#x000a0;&#x0003c;&#x000a0;148&#x000a0;pmol/L), marginal deficit (B12&#x000a0;&#x02265;&#x000a0;148 and &#x0003c;221&#x000a0;pmol/L), and normal (B12&#x000a0;&#x02265;&#x000a0;221&#x000a0;pmol/L) as suggested by Morris et al. [<xref ref-type="bibr" rid="CR10">10</xref>]. Folates were categorized using the cut off points suggested by Pfeifer (as supra physiologic folate level &#x02265;45.3&#x000a0;nmol/l) [<xref ref-type="bibr" rid="CR6">6</xref>]. A logistic regression served to analyze the association between Vit B12 and folate and the percentage of methylation in specific CpG sites. CpG methylation was categorized in tertiles being the 3rd tertile the most methylated [<xref ref-type="bibr" rid="CR26">26</xref>]. These results were adjusted by age, sex, body mass index (BMI), tobacco, and vitamin metabolites (HoloTC, tHcy, and MMA). We considered that tumor suppressor and DNA repair-related genes would be highly expressed thus conferring protection from risk of cancer. All statistical analyses were performed using STATA 14 software (StataCorp. 2015. Stata Statistical Software, Release 14. College Station, TX, StataCorp LP).</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Subjects</title><p id="Par32">Descriptive data for the participants are shown in Table <xref rid="Tab1" ref-type="table">1</xref>. The subjects were a representative sample of the respective age group within the population of low socio economic level elderly Chileans [<xref ref-type="bibr" rid="CR9">9</xref>] with a relatively low education level (median 6&#x000a0;years); no sex differences were noted. Women consumed twice as much antidepressant and antihypertensive drugs than men (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). Cognitive status assessed by the Mini Mental State Examination (MMSE) [<xref ref-type="bibr" rid="CR32">32</xref>] was lower in women than in men; however, that difference was clinically irrelevant; men and women had scores within the accepted normal range for age (MMSE &#x02265;21&#x02013;22). BMI was slightly higher in women than in men (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). Smoking rates was low in the participants and however higher in men compared to women (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Men<break/>(<italic>n</italic>&#x000a0;=&#x000a0;77)</th><th>Women<break/>(<italic>n</italic>&#x000a0;=&#x000a0;172)</th><th>Total<break/>(<italic>n</italic>&#x000a0;=&#x000a0;249)</th></tr></thead><tbody><tr><td colspan="4">Age (years)<sup>a</sup>
</td></tr><tr><td>&#x02003;mean&#x000a0;&#x000b1;&#x000a0;SD</td><td>73.5&#x000a0;&#x000b1;&#x000a0;2.7</td><td>73.9&#x000a0;&#x000b1;&#x000a0;3.1</td><td>73.8&#x000a0;&#x000b1;&#x000a0;3.0</td></tr><tr><td>&#x02003;95% CI</td><td>72.9&#x02013;74.1</td><td>73.5&#x02013;74.4</td><td>73.4&#x02013;74.2</td></tr><tr><td colspan="4">&#x02003;Education (years)</td></tr><tr><td>&#x02003;median (p25&#x02013;p75)<sup>b</sup>
</td><td>6 (4&#x02013;8)</td><td>6 (8&#x02013;3)</td><td>6 (8&#x02013;3)</td></tr><tr><td>&#x02003;&#x02264;6&#x000a0;years % (<italic>n</italic>)<sup>c</sup>
</td><td>56.6 (43)</td><td>63.7 (107)</td><td>61.5 (150)</td></tr><tr><td>&#x02003;95% CI</td><td>44.7&#x02013;67.9</td><td>55.9&#x02013;71.0</td><td>55.1&#x02013;67.6</td></tr><tr><td colspan="4">Medication (number)***<sup>c</sup>
</td></tr><tr><td>&#x02003;0, % (<italic>n</italic>)</td><td>23.4 (18)</td><td>11.1 (19)</td><td>14.9 (37)</td></tr><tr><td>&#x02003;95% CI</td><td>14.5&#x02013;34.4</td><td>6.8&#x02013;16.7</td><td>10.7&#x02013;19.9</td></tr><tr><td>&#x02003;1, % (<italic>n</italic>)</td><td>19.5 (15)</td><td>10.5 (18)</td><td>13.3 (33)</td></tr><tr><td>&#x02003;95% CI</td><td>11.3&#x02013;30.1</td><td>6.3&#x02013;16.0</td><td>9.3&#x02013;18.1</td></tr><tr><td>&#x02003;2&#x02013;3, % (<italic>n</italic>)</td><td>36.4 (28)</td><td>34.9 (60)</td><td>35.3 (88)</td></tr><tr><td>&#x02003;95% CI</td><td>25.7&#x02013;48.1</td><td>27.8&#x02013;42.5</td><td>29.4&#x02013;41.6</td></tr><tr><td>&#x02003;4+, % (<italic>n</italic>)</td><td>20.8 (16)</td><td>43.6 (75)</td><td>36.6 (91)</td></tr><tr><td>&#x02003;95% CI</td><td>12.4&#x02013;31.5</td><td>36.1&#x02013;51.4</td><td>30.5&#x02013;42.9</td></tr><tr><td colspan="4">MMSE*<sup>b</sup>
</td></tr><tr><td>&#x02003;median (p25&#x02013;p75)</td><td>28 (26&#x02013;29)</td><td>27 (25&#x02013;29)</td><td>27 (25&#x02013;29)</td></tr><tr><td>BMI*<sup>a</sup>
</td><td/><td/><td/></tr><tr><td>&#x02003;BMI*<sup>a</sup> mean&#x000a0;&#x000b1;&#x000a0;SD</td><td>26.9&#x000a0;&#x000b1;&#x000a0;3.2</td><td>28.5&#x000a0;&#x000b1;&#x000a0;5.1</td><td>28.1&#x000a0;&#x000b1;&#x000a0;4.7</td></tr><tr><td>&#x02003;95% CI</td><td>26.2&#x02013;27. 7</td><td>27.7&#x02013;29.3</td><td>27.4&#x02013;28.6</td></tr><tr><td colspan="4">Tobacco consumption**<sup>c</sup>
</td></tr><tr><td>&#x02003;% (<italic>n</italic>)</td><td>10.5 (8)</td><td>5.8 (10)</td><td>7.3 (18)</td></tr><tr><td>&#x02003;CI 95%</td><td>4.6&#x02013;19.4</td><td>2.8&#x02013;10.4</td><td>4.3&#x02013;11.2</td></tr></tbody></table><table-wrap-foot><p>Medications frequently used in elderly: antihypertensive, anti-inflammatory, antidepressant</p><p>
<italic>BMI</italic> Body Mass Index, <italic>MMSE</italic> Minimental state examination</p><p>*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01; ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001</p><p>
<sup>a</sup>Two-sample mean-comparison test</p><p>
<sup>b</sup>Two-sample Wilcoxon rank-sum test</p><p>
<sup>c</sup>Pearson&#x02019;s&#x000a0;Chi<sup>2</sup> test</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec9"><title>Methylation of genes</title><p id="Par33">Table <xref rid="Tab2" ref-type="table">2</xref> describes DNA methylation for all genes studied as the percentage of methylation. We observed high methylation of <italic>LINE-1</italic> sequences, as expected [<xref ref-type="bibr" rid="CR39">39</xref>]. In general, the percentage of methylation of the tumor suppressor and DNA repair genes studied were low (1.1 to 4.17%), suggesting that these genes were highly expressed [<xref ref-type="bibr" rid="CR40">40</xref>]. No differences related with sex were observed in methylation status.<table-wrap id="Tab2"><label>Table 2</label><caption><p>DNA methylation in specific CpG sites</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>CpG site</th><th>Men (<italic>n</italic>&#x000a0;=&#x000a0;77)</th><th>Women (<italic>n</italic>&#x000a0;=&#x000a0;172)</th><th>Total (<italic>n</italic>&#x000a0;=&#x000a0;249)</th></tr></thead><tbody><tr><td rowspan="5">
<italic>LINE-1</italic>
</td><td>1</td><td>86.2 (84.5&#x02013;86.9)</td><td>85.75 (84.5&#x02013;86.9)</td><td>85.8 (84.8&#x02013;86.7)</td></tr><tr><td>2</td><td>82.6 (82.3&#x02013;82.8)</td><td>82.5 (82.2&#x02013;82.8)</td><td>82.5 (82.3&#x02013;82.7)</td></tr><tr><td>3</td><td>80.875 (80.4&#x02013;81.75)</td><td>80.9 (80.3&#x02013;81.3)</td><td>80.9 (80.5&#x02013;81.2)</td></tr><tr><td>4</td><td>82.2 (81.3&#x02013;83.2)</td><td>82.0 (81.6&#x02013;82.4)</td><td>82.0 (81.7&#x02013;82.4)</td></tr><tr><td>Average</td><td>83.3 (82.8&#x02013;83.8)</td><td>82.8 (82.6&#x02013;83.3)</td><td>82.9 (82.65&#x02013;83.4)</td></tr><tr><td rowspan="8">
<italic>p16</italic>
</td><td>1</td><td>3.36 (3.0&#x02013;3.89)</td><td>3.46 (3.25&#x02013;3.64)</td><td>3.44 (3.25&#x02013;3.6)</td></tr><tr><td>2</td><td>1.575 (1.16&#x02013;1.9)</td><td>1.58 (1.45&#x02013;1.87)</td><td>1.58 (1.46&#x02013;1.79)</td></tr><tr><td>3</td><td>1.88 (1.37&#x02013;2.12)</td><td>1.84 (1.62&#x02013;2.07)</td><td>1.85 (1.66&#x02013;2.04)</td></tr><tr><td>4*</td><td>2.2 (1.91&#x02013;2.25)</td><td>1.88 (1.75&#x02013;2.05)</td><td>1.96 (1.82&#x02013;2.11)</td></tr><tr><td>5</td><td>0.91 (0&#x02013;1.60)</td><td>1.65 (1.41&#x02013;1.92)</td><td>1.49 (1.34&#x02013;1.77)</td></tr><tr><td>6</td><td>0</td><td>0</td><td>0</td></tr><tr><td>7</td><td>1.89 (1.38&#x02013;2.23)</td><td>1.94 (1.73&#x02013;2.12)</td><td>1.91 (1.71&#x02013;2.09)</td></tr><tr><td>Average</td><td>1.89 (1.66&#x02013;2.06)</td><td>1.92 (1.78&#x02013;2.02)</td><td>1.907 (1.79&#x02013;2.01)</td></tr><tr><td rowspan="5">
<italic>MLH1</italic>
</td><td>1</td><td>0 (0&#x02013;0.99)</td><td>0</td><td>0</td></tr><tr><td>2</td><td>1.39 (0&#x02013;2.35)</td><td>1.82 (0&#x02013;2.10)</td><td>1.725 (0&#x02013;2.07)</td></tr><tr><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td>4<sup>&#x003b3;</sup>
</td><td>2.3 (1.75&#x02013;2.80)</td><td>2.495 (1.96&#x02013;2.84)</td><td>2.435 (1.97&#x02013;2.77)</td></tr><tr><td>Average</td><td>1.25 (0.70&#x02013;1.38)</td><td>1.12 (0.74&#x02013;1.31)</td><td>1.165 (0.81&#x02013;1.31)</td></tr><tr><td rowspan="7">
<italic>MGMT</italic>
</td><td>1</td><td>3.345 (2.53&#x02013;4.21)</td><td>4.01 (3.51&#x02013;4.66)</td><td>3.8 (3.41&#x02013;4.26)</td></tr><tr><td>2</td><td>0 (0&#x02013;1.65)</td><td>0 (0&#x02013;1.88)</td><td>0</td></tr><tr><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td>4</td><td>1.865 (1.38&#x02013;2.31)</td><td>1.87 (1.61&#x02013;2.26)</td><td>1.87 (1.61&#x02013;2.15)</td></tr><tr><td>5</td><td>0</td><td>0</td><td>0</td></tr><tr><td>6</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Average</td><td>1.555 (1.10&#x02013;2.11)</td><td>1.72 (1.39&#x02013;1.87)</td><td>1.66 (1.44&#x02013;1.87)</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as percentages of methylation and 95% CI. Two-sample Wilcoxon rank-sum test *<italic>p</italic>&#x000a0;=&#x000a0;0.04; <sup>&#x003b3;</sup>
<italic>p</italic>&#x000a0;=&#x000a0;0.07; for other results <italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.1</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Blood determinations</title><p id="Par34">The concentrations of vitamins in serum are shown in Table <xref rid="Tab3" ref-type="table">3</xref>. Deficient concentrations of Vit B12 (&#x0003c;148&#x000a0;pmol/L) were present in 11.1% of the participants while 78.4% showed Vit B12 concentrations &#x02265;221&#x000a0;pmol/L, with 29% of them having high Vit B12 concentrations (&#x0003e;680&#x000a0;pmol/L). It is likely that these subjects were taking vitamin supplements. HoloTC was higher in women than in men (<italic>p</italic>&#x000a0;=&#x000a0;0.029), although HoloTC concentrations in both men and women were within the normal range (40&#x02013;200&#x000a0;pmol/L) [<xref ref-type="bibr" rid="CR41">41</xref>]. MMA concentrations were within the normal range indicate Vit B12 deficiency (MMA &#x02264;400&#x000a0;nmol/L) [<xref ref-type="bibr" rid="CR42">42</xref>]. Serum folate concentrations were 36&#x000a0;nmol/L (median; p25&#x02013;p75&#x000a0;=&#x000a0;24&#x02013;253.8) slightly higher in women compared with men (<italic>p</italic>&#x000a0;=&#x000a0;0.0499). Interestingly, 31.1% of the participants showed high serum folate concentrations (&#x0003e;45.3&#x000a0;nmol/L): 34.1% of women compared with 24.3% of men (<italic>p</italic>&#x000a0;=&#x000a0;0.031). Homocysteine levels were within normal reference range (&#x0003c;15&#x000a0;&#x003bc;mol/L) [<xref ref-type="bibr" rid="CR43">43</xref>] without sex differences.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Blood level of vitamins and metabolites</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Men<break/>(<italic>n</italic>&#x000a0;=&#x000a0;66)</th><th>Women<break/>(<italic>n</italic>&#x000a0;=&#x000a0;142)</th><th>Total<break/>(<italic>n</italic>&#x000a0;=&#x000a0;208)</th></tr></thead><tbody><tr><td>Vitamin B12 (pmol/L) Median<break/>(p25&#x02013;p75)</td><td>370.7<break/>(221.9&#x02013;683.0)</td><td>438.5<break/>(215.4&#x02013;767.5)</td><td>409.3<break/>(218.8&#x02013;729.3)</td></tr><tr><td align="right">&#x0003c;148&#x000a0;pmol/L % (<italic>n</italic>)<break/>(95% CI)</td><td>10.6(7)<break/>(4.4&#x02013;20.6)</td><td>11.3(16)<break/>(6.6&#x02013;17.7)</td><td>11.1(23)<break/>(7.1&#x02013;16.1)</td></tr><tr><td align="right">148&#x02013;221&#x000a0;pmol/L % (<italic>n</italic>)<break/>(95% CI)</td><td>12.1(8)<break/>(5.4&#x02013;22.5)</td><td>9.9(14)<break/>(5.5&#x02013;16)</td><td>10.6(22)<break/>(6.7&#x02013;15.6)</td></tr><tr><td align="right">&#x0003e;221&#x000a0;pmol/L % (<italic>n</italic>)<break/>(95% CI)</td><td>77.3(51)<break/>(65.3&#x02013;86.7)</td><td>78.9(112)<break/>(71.2&#x02013;85.3)</td><td>78.4(163)<break/>(72.1&#x02013;83.8)</td></tr><tr><td>MMA (nmol/L) Median<break/>(p25&#x02013;p75)</td><td>187<break/>(145&#x02013;247)</td><td>177.5<break/>(143&#x02013;269)</td><td>180<break/>(143&#x02013;266)</td></tr><tr><td>HoloTC (pmol/L) Median<break/>(p25&#x02013;p75)</td><td>67.7<break/>(46.8&#x02013;121.3)</td><td>102.9**<break/>(56&#x02013;171.3)</td><td>180<break/>(143&#x02013;266)</td></tr><tr><td>Folates (nmol/L) Median<break/>(p25&#x02013;p75)</td><td>34.6<break/>(20.3&#x02013;44.9)</td><td>36.6*<break/>(25.3&#x02013;61.5)</td><td>36<break/>(24.253.8)</td></tr><tr><td align="right">&#x0003e;45.3&#x000a0;nmol/L % (<italic>n</italic>)<break/>(95% CI)</td><td>24.3(18)<break/>(15.1&#x02013;35.7)</td><td>34.1(57)<sup>&#x003b3;</sup>
<break/>(27.0&#x02013;41.9)</td><td>31.1(75)<break/>(25.3&#x02013;37.4)</td></tr><tr><td>Homocysteine (&#x003bc;mol/L) Median<break/>(p25&#x02013;p75)</td><td>11.3<break/>(9.3&#x02013;12.7)</td><td>10.6<break/>(8.7&#x02013;13.2)</td><td>10.8<break/>(8.7&#x02013;13.1)</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as median (p25&#x02013;p75) and % (<italic>n</italic>) and 95% CI</p><p>
<italic>MMA</italic> methylmalonic acid, <italic>HoloTC</italic> holotranscobalamin</p><p>*<italic>p</italic>&#x000a0;=&#x000a0;0.0499, two-sample Wilcoxon rank sum test; **<italic>p</italic>&#x000a0;=&#x000a0;0.029; <sup>&#x003b3;</sup>
<italic>p</italic>&#x000a0;=&#x000a0;0.031, Chi<sup>2</sup> test</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec11"><title>Analysis of correlations and regression models</title><p id="Par35">Table <xref rid="Tab4" ref-type="table">4</xref> shows correlations between the vitamins and DNA methylation in studied genes. No correlation was found between vitamins and methylation in <italic>LINE-1</italic>. Vit B12 and folates correlated with DNA methylation in specific CpG sites of <italic>p16</italic>, <italic>MGMT</italic>, and <italic>MLH1</italic> genes. For <italic>p16</italic>, Vit B12 was positively correlated with DNA methylation in CpG 1, 3, and 5 and with average methylation, and folates correlated positively with CpG sites 3 and 5. For <italic>MLH1</italic>, Vit B12 correlated negatively with methylation of CpG site 1, and folates correlated positively with CpG 2, 4 and average <italic>MLH1</italic> methylation. For <italic>MGMT</italic>, Vit B12 correlated positively with CpG 2, and folates correlated positively with methylation of CpG sites 1&#x02013;3 and average and negatively with CpG4. Concentrations of HoloTC, Hcy, and MMA did not correlate with methylation in the DNA of any studied gene.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Spearman correlation for blood concentrations of vitamins and metabolites and DNA methylation in specific CpG sites of <italic>LINE-1</italic>, <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT </italic>genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>CpG site</th><th>Vit B12 <italic>n</italic>&#x000a0;=&#x000a0;242</th><th>Folates <italic>n</italic>&#x000a0;=&#x000a0;241</th><th>HoloTC <italic>n</italic>&#x000a0;=&#x000a0;193</th><th>Hcy <italic>n</italic>&#x000a0;=&#x000a0;193</th><th>MMA <italic>n</italic>&#x000a0;=&#x000a0;193</th></tr></thead><tbody><tr><td rowspan="5">
<italic>LINE-1</italic>
</td><td>1</td><td>&#x02212;0.1064</td><td>0.0193</td><td>&#x02212;0.1357</td><td>0.0509</td><td>0.0298</td></tr><tr><td>2</td><td>&#x02212;0.0106</td><td>&#x02212;0.1259</td><td>&#x02212;0.0680</td><td>&#x02212;0.0811</td><td>0.1004</td></tr><tr><td>3</td><td>0.1067</td><td>0.0360</td><td>0.1321</td><td>&#x02212;0.0644</td><td>&#x02212;0.0318</td></tr><tr><td>4</td><td>&#x02212;0.0346</td><td>&#x02212;0.0127</td><td>&#x02212;0.1313</td><td>0.0281</td><td>0.0394</td></tr><tr><td>Average</td><td>&#x02212;0.0373</td><td>0.0302</td><td>&#x02212;0.1135</td><td>0.0604</td><td>0.0166</td></tr><tr><td rowspan="7">
<italic>p16</italic>
</td><td>1</td><td>0.1888*</td><td>0.0156</td><td>0.1152</td><td>&#x02212;0.0002</td><td>&#x02212;0.0137</td></tr><tr><td>2</td><td>&#x02212;0.0552</td><td>&#x02212;0.1519</td><td>0.0104</td><td>&#x02212;0.0239</td><td>&#x02212;0.0303</td></tr><tr><td>3</td><td>0.2965*</td><td>0.2320*</td><td>0.1137</td><td>&#x02212;0.1293</td><td>&#x02212;0.1288</td></tr><tr><td>5</td><td>0.2198*</td><td>0.2974*</td><td>0.0595</td><td>&#x02212;0.0462</td><td>&#x02212;0.1619</td></tr><tr><td>6</td><td>&#x02212;0.1668</td><td>&#x02212;0.1787</td><td>&#x02212;0.0167</td><td>0.0709</td><td>0.0449</td></tr><tr><td>7</td><td>0.0863</td><td>&#x02212;0.1029</td><td>0.1230</td><td>0.0455</td><td>&#x02212;0.0597</td></tr><tr><td>Average</td><td>0.2288*</td><td>0.0867</td><td>0.1553</td><td>&#x02212;0.0880</td><td>&#x02212;0.1318</td></tr><tr><td rowspan="5">
<italic>MLH1</italic>
</td><td>1</td><td>&#x02212;0.2809*</td><td>&#x02212;0.1616</td><td>0.0360</td><td>&#x02212;0.0555</td><td>&#x02212;0.0634</td></tr><tr><td>2</td><td>0.0977</td><td>0.2453*</td><td>&#x02212;0.0248</td><td>&#x02212;0.0422</td><td>&#x02212;0.0656</td></tr><tr><td>3</td><td>&#x02212;0.1404</td><td>&#x02212;0.1102</td><td>&#x02212;0.0374</td><td>&#x02212;0.0393</td><td>&#x02212;0.0451</td></tr><tr><td>4</td><td>0.1246</td><td>0.3121*</td><td>0.0399</td><td>&#x02212;0.1387</td><td>&#x02212;0.1486</td></tr><tr><td>Average</td><td>&#x02212;0.1081</td><td>0.1786*</td><td>0.0188</td><td>&#x02212;0.1410</td><td>&#x02212;0.1478</td></tr><tr><td rowspan="7">
<italic>MGMT</italic>
</td><td>1</td><td>0.1118</td><td>0.2291*</td><td>&#x02212;0.0167</td><td>&#x02212;0.0589</td><td>&#x02212;0.0211</td></tr><tr><td>2</td><td>0.3142*</td><td>0.4196*</td><td>&#x02212;0.0082</td><td>&#x02212;0.0702</td><td>&#x02212;0.1504</td></tr><tr><td>3</td><td>0.0791</td><td>0.2007*</td><td>&#x02212;0.0522</td><td>&#x02212;0.0417</td><td>&#x02212;0.0876</td></tr><tr><td>4</td><td>&#x02212;0.1561</td><td>&#x02212;0.3457*</td><td>0.0002</td><td>0.0808</td><td>0.1207</td></tr><tr><td>5</td><td>&#x02212;0.1187</td><td>&#x02212;0.1011</td><td>&#x02212;0.0570</td><td>&#x02212;0.0621</td><td>&#x02212;0.0806</td></tr><tr><td>6</td><td>&#x02212;0.0111</td><td>&#x02212;0.0272</td><td>&#x02212;0.0012</td><td>&#x02212;0.1773</td><td>&#x02212;0.1511</td></tr><tr><td>Average</td><td>0.1168</td><td>0.2489*</td><td>&#x02212;0.0591</td><td>&#x02212;0.0567</td><td>&#x02212;0.0474</td></tr></tbody></table><table-wrap-foot><p>*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01</p></table-wrap-foot></table-wrap>
</p><p id="Par36">A logistic regression model (Table <xref rid="Tab5" ref-type="table">5</xref>) was used to evaluate possible associations between high folate (&#x0003e;45.3&#x000a0;nmol/L) and low Vit B12 concentrations (&#x0003c; 148 and between 148&#x000a0;&#x0003c;&#x000a0;221&#x000a0;pmol/L) with DNA methylation of tumor suppressor and repair genes above the 3rd tertile that might lead to a lower expression. For <italic>p16</italic>, folate concentrations &#x0003e;45.3&#x000a0;nmol/L were significantly associated with risk of increased DNA methylation of CpG sites 3 and 5, with an OR of 1.97 and 4.17, respectively (Table <xref rid="Tab5" ref-type="table">5</xref>). For <italic>MLH1</italic>, high folate level was significantly associated with risk of increased mean DNA methylation (OR: 2.2) and also to increased DNA methylation of CpG sites 1&#x02013;3 (OR: 2.31, 3.73, and 2.08, respectively) (Table <xref rid="Tab5" ref-type="table">5</xref>). For <italic>MGMT</italic>, high folate level was associated risk of increased average DNA methylation (OR: 2.84) and increased DNA methylation of CpG site 4 (OR: 3.91). No significant associations were observed between low Vit B12 (&#x0003c;148&#x000a0;nmol/L) and DNA methylation.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Logistic Regression Model between vitamin B12 and folate levels and the risk of methylation of <italic>p16</italic>, <italic>MLH1</italic>, and <italic>MGMT</italic> at the 3rd tertile (%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="4"/><th colspan="2">Vit&#x000a0;B12 (pmol/L)</th><th>Folates* (nmol/L)</th></tr><tr><th>&#x0003c;148</th><th>148&#x02013;221</th><th>&#x0003e;45.3</th></tr></thead><tbody><tr><td rowspan="4">
<italic>p16</italic>
</td><td rowspan="16">CpG<break/>site</td><td rowspan="2">3<sup>a</sup>
</td><td>OR</td><td>0.70</td><td>0.36</td><td>1.97</td></tr><tr><td>95% CI</td><td>0.23&#x02013;2.08</td><td>0.10&#x02013;1.23</td><td>1.04&#x02013;3.75</td></tr><tr><td rowspan="2">5<sup>b</sup>
</td><td>OR</td><td>0.46</td><td>0.67</td><td>4.17</td></tr><tr><td>95% CI</td><td>0.13&#x02013;1.6</td><td>0.2&#x02013;2.2</td><td>2.12&#x02013;8.19</td></tr><tr><td align="center" rowspan="8">
<italic>MLH1</italic>
</td><td rowspan="2">1<sup>c</sup>
</td><td>OR</td><td>0.56</td><td>0.93</td><td>2.31</td></tr><tr><td>95% CI</td><td>0.14&#x02013;2.19</td><td>0.28&#x02013;3.13</td><td>1.15&#x02013;4.64</td></tr><tr><td rowspan="2">2<sup>d</sup>
</td><td>OR</td><td>0.43</td><td>0.86</td><td>3.73</td></tr><tr><td>95% CI</td><td>0.10&#x02013;1.88</td><td>0.26&#x02013;2.90</td><td>1.83&#x02013;7.59</td></tr><tr><td rowspan="2">3<sup>e</sup>
</td><td>OR</td><td>1.18</td><td>1.22</td><td>2.08</td></tr><tr><td>95% CI</td><td>0.34&#x02013;4.13</td><td>0.38&#x02013;3.95</td><td>1.03&#x02013;4.20</td></tr><tr><td rowspan="2">Average<sup>f</sup>
</td><td>OR</td><td>0.99</td><td>1.60</td><td>2.20</td></tr><tr><td>95% CI</td><td>0.26&#x02013;3.80</td><td>0.48&#x02013;5.32</td><td>1.08&#x02013;4.50</td></tr><tr><td align="center" rowspan="4">
<italic>MGMT</italic>
</td><td rowspan="2">4<sup>g</sup>
</td><td>OR</td><td>0.96</td><td>0.12</td><td>3.91</td></tr><tr><td>95% CI</td><td>0.28&#x02013;3.26</td><td>0.014&#x02013;0.99</td><td>1.88&#x02013;8.11</td></tr><tr><td rowspan="2">Average<sup>h</sup>
</td><td>OR</td><td>0.92</td><td>0.6</td><td>2.84</td></tr><tr><td>95% CI</td><td>0.28&#x02013;2.98</td><td>0.19&#x02013;2.52</td><td>1.42&#x02013;5.69</td></tr></tbody></table><table-wrap-foot><p>Adjusted by sex, age, tobacco, BMI, Hcy, HoloTC, and MMA</p><p>
<italic>OR</italic> odd ratio, <italic>CI</italic> confidence interval</p><p>*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 vs folate &#x0003c;45.3&#x000a0;nmol/L</p><p>
<sup>a</sup>&#x0003c;&#x000a0;2.35% methylation</p><p>
<sup>b</sup>2.11%&#x000a0;methylation</p><p>
<sup>c</sup>&#x0003c;&#x000a0;5.24%&#x000a0;methylation</p><p>
<sup>d</sup>&#x0003c;&#x000a0;2.65%&#x000a0;methylation</p><p>
<sup>e</sup>&#x000a0;&#x0003c;&#x000a0;0.34%&#x000a0;methylation</p><p>
<sup>f</sup>&#x0003c;&#x000a0;2.14%&#x000a0;methylation</p><p>
<sup>g</sup>&#x0003c;&#x000a0;3.2%&#x000a0;methylation</p><p>
<sup>h</sup>&#x0003c;&#x000a0;1.48%&#x000a0;methylation</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par37">In this study, we found that about one third of the participants, who have been exposed to FA during 12&#x000a0;years through wheat flour fortification, show a mean circulating folate concentrations higher than 45.3&#x000a0;nmol/L, described as supra physiological [<xref ref-type="bibr" rid="CR6">6</xref>]. More women than men registered supra physiological folate concentrations (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.031). Also, circulating folate concentrations were slightly higher in women than in men (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.0499). These results demonstrate that there is probably no folate deficiency in the Chilean population, including the elderly, which may be a consequence of the mandatory public policy of fortifying wheat flour with FA to prevent neonates NTD initiated in Chile the year 2000 [<xref ref-type="bibr" rid="CR2">2</xref>]. Other important finding is that high serum folate levels increase DNA methylation of tumor suppressor genes <italic>p16</italic> and DNA repair genes <italic>MLH1</italic> and <italic>MGMT</italic> in blood. Folate concentrations &#x0003e;45.3&#x000a0;nmol/L increased the risk of methylation in the 3rd tertile in specific CpG sites of the genes <italic>p16</italic> (CpG 5, OR&#x000a0;=&#x000a0;4.17), <italic>MLH1</italic> (CpG 2, OR&#x000a0;=&#x000a0;3.73), and <italic>MGMT</italic> (CpG4, OR&#x000a0;=&#x000a0;3.91). Also, high folate concentrations increased the risk of methylation in the average DNA methylation of <italic>MGMT</italic> and <italic>MLH1</italic>.</p><p id="Par38">Due to the essentiality of folates during pregnancy, and to prevent NTD in newborns, several countries, including Chile, started food FA fortification programs to cover requirements of the target population (600&#x000a0;&#x003bc;g/day). However, this policy has led to elevate blood levels of the whole population; estimations are that 20 to 30% of the general population present serum folate concentrations over 40&#x000a0;nmol/L [<xref ref-type="bibr" rid="CR29">29</xref>]. Previous studies found a high incidence of Vit B12 deficiency in elderly Chilean, and it was suggested that those deficiency was masked by high folate levels as a consequence of the food fortification policy of with folates [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This evidence led to the Health Ministry of the Chilean government to implement a program for older adults, users of the public health system, which provided them periodically with milk or a packaged soup fortified with Vit B12. This may explain that in the present study, only 11.1% of the participants presented Vit B12 deficiency (Table <xref rid="Tab3" ref-type="table">3</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par39">Increased circulating folate concentrations have also been considered a risk factor for cardiovascular disease [<xref ref-type="bibr" rid="CR44">44</xref>] and some forms of cancer [<xref ref-type="bibr" rid="CR45">45</xref>]. Epidemiologic studies carried out in the USA, Canada [<xref ref-type="bibr" rid="CR46">46</xref>], and Chile [<xref ref-type="bibr" rid="CR29">29</xref>] have reported a temporal relationship between mandatory fortification with FA and a greater incidence of colorectal cancer related to the beginning of the fortification programs.</p><p id="Par40">Men with high blood folate levels were at greater risk of high-grade (more aggressive) prostate cancer compared with men with lower folate levels [<xref ref-type="bibr" rid="CR47">47</xref>]. The Women&#x02019;s Health Initiative Observational Study cohort provided new evidence that increased folate intake during the early post-fortification period may have been associated with a transient increase in colorectal cancer risk [<xref ref-type="bibr" rid="CR48">48</xref>]. In a population-based study from northern Sweden, a bell-shaped relationship between plasma folate concentrations and colorectal cancer risk was observed, with a doubling of risk for subjects in the middle versus lowest quintile [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par41">On the contrary, a recent study with more than 1400 older adults (&#x02265;57&#x000a0;years) with a median follow-up of 6.3&#x000a0;years showed that high total folate intake appear to be protective against cancer in post-FA fortification years. Those authors did not find significant associations between the presence of non-metabolized FA, intake of naturally-occurring food folate or FA separately, and cancer incidence [<xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par42">Probably, folates like other compounds and vitamins may have a U shape effects, with hazardous effects with both low and high levels.</p><p id="Par43">Folate homeostasis disruption (by high or low levels of folate intake) may change the one-carbon metabolism, the process responsible for production of methyl groups, leading to gene transcription alterations (overexpression and/or gene silencing) through DNA gene hyper- or hypo-methylation reactions. Disruption of epigenetic processes can in turn lead to altered gene and cell functions leading to malignancy. Recent advancements in the rapidly evolving field of cancer epigenetics have shown extensive reprogramming of every component of the epigenetic machinery in cancer, including DNA methylation [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par44">It should be noted that we here analyzed associations between FA and DNA methylation in blood and we do not know if the observed changes in DNA methylation actually are present in the target tissues or associated with cancer incidence. Tumor suppressor genes become inactive with hypermethylation of their promoter regions, and aberrant promoter methylation of tumor suppressor genes is associated with different types of cancers [<xref ref-type="bibr" rid="CR51">51</xref>] and its serum detection may be a good marker for cancer diagnosis [<xref ref-type="bibr" rid="CR52">52</xref>]. Recent publications have found that in cervical, colon, breast, bladder, gastric, lung, and esophageal tumors, tumor suppressor genes like <italic>p15, p16, p21, p27, p57</italic>, and others are hypermethylated in their promoters [<xref ref-type="bibr" rid="CR53">53</xref>]. Moreover, <italic>p16</italic> hypermethylation was found to be an independent prognostic marker for cancer-specific survival. Still, our hypotheses about the effects of folic acid and vitamin B12 on epigenetic processes in relation to tumor suppressor inactivation warrant further investigation and confirmation in future research following up the cancer incidence among individuals with varying tumor suppressor methylation in blood.</p><p id="Par45">The availability of dietary factors involved in one-carbon metabolism may contribute to aberrant DNA methylation [<xref ref-type="bibr" rid="CR54">54</xref>]. A recent study on 87 elderly (65&#x02013;75&#x000a0;years) showed that long-term supplementation of FA and Vit B12 (2&#x000a0;years) resulted in effects on DNA methylation of several genes implicated in carcinogenesis and early embryonic development [<xref ref-type="bibr" rid="CR55">55</xref>]; genome-wide methylation analysis revealed pronounced methylation changes in the DIRAS3, ARMC8, and NODAL genes. Further, among positions that were differentially methylated after the intervention with FA and Vit B12, CpG positions within CpG islands and around transcription start sites were overrepresented. This suggests that the availability of folate affects DNA methylation at specific DNA regions. Also, other factors that seem to affect DNA methylation, e.g., for p16 including tobacco, radiation exposure, and pollution, have been associated with aberrant methylation of this gene, and its detection in blood or in serum has been suggested to be a good marker for cancer diagnosis [<xref ref-type="bibr" rid="CR25">25</xref>]. The percentages of DNA methylation in LINE-1, <italic>p16</italic>, and <italic>MLH1</italic> in the present study are comparable to the methylation levels found in younger Argentinean women exposed to arsenic, although they were on average slightly lower (Argentinean 3.4 vs. Chilean 1.9% for <italic>p16</italic>; Argentinean 4.2 vs. Chilean 1.17 [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Significant correlation between folates and methylation at specific CpG sites of <italic>p16</italic> and <italic>MLH1</italic> were different from those linked to arsenic exposure; in this study, we found correlations with methylation of <italic>p16</italic> sites 3 and 5 and <italic>MLH1</italic> site 4, compared with sites 1 both in <italic>p16</italic> and <italic>MLH1</italic> associated with arsenic exposure. Stronger correlations were observed for methylation of several sites in <italic>MGMT</italic> with folates. This suggests that exposure to different compounds may disrupt DNA methylation at different genes and sites.</p><p id="Par46">One limitation of this study is the lack of RNA to assess gene expression and the respective association with the level of DNA methylation, and that we did not follow the cancer incidence in this cohort. However, there is enough information to expect that a hypermethylated gene is less expressed than a hypomethylated gene [<xref ref-type="bibr" rid="CR56">56</xref>]. A highlight of this study is the homogeneity of the sample, since all of the participants have been exposed to wheat flour fortification with FA.</p><p id="Par47">In summary, we conclude that long time exposure to highly consumed FA-fortified foods by a non-target population increase blood concentrations of circulating folates inducing to a higher risk of higher gene-specific methylation levels. Although marginal, the increased methylation levels of tumor suppressor and DNA repair genes may reduce their gene expression that are in turn associated with increased risk of some cancers.</p></sec><sec id="Sec13"><title>Conclusions</title><p id="Par48">Elderly Chilean exposed to fortified foods with FA during the last 12&#x000a0;years do not present folate deficiency and have normal or elevated levels of circulating folates. Folate concentrations &#x0003e;45.3&#x000a0;nmol/L increased the risk of methylation in specific CpG sites of tumor suppressor and DNA repair genes.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AF</term><def><p id="Par6">Folic acid</p></def></def-item><def-item><term>CV</term><def><p id="Par7">Coefficient of variance</p></def></def-item><def-item><term>HoloTC</term><def><p id="Par8">Holotranscobalamin</p></def></def-item><def-item><term>LINE-1</term><def><p id="Par9">Long interspersed nuclear element 1</p></def></def-item><def-item><term>MMA</term><def><p id="Par10">Methyl malonic acid</p></def></def-item><def-item><term>MMSE</term><def><p id="Par11">Mini-Mental State Examination score</p></def></def-item><def-item><term>NTD</term><def><p id="Par12">Neural tube disease</p></def></def-item><def-item><term>OR</term><def><p id="Par13">Odd ratio</p></def></def-item><def-item><term>tHcy</term><def><p id="Par14">Total homocysteine</p></def></def-item><def-item><term>Vit B12</term><def><p id="Par15">Vitamin B12</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors would like to thank all participants of this study.</p><sec id="FPar1"><title>Funding</title><p id="Par49">The authors would like to thank Fondo Nacional de Ciencia y Tecnolog&#x000ed;a (FONDECYT), Gobierno de Chile (#1070592 to RU and&#x000a0;# 1130188 to AMR), and the Swedish Council for Working Life and Social Research FORTE to KB.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par50">The datasets used and analyzed during the current study are available from the first author (HS) on reasonable request.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>HS, KB, and AMR contributed to the conception and design of the study. KB, MBH, CA, SH, RU, and AMR contributed to the major portion of the manuscript writing and editing. MBH contributed in performing the methylation experiments. LL and SH contributed to performing statistical analyses. RU, KB, and AMR contributed in funding. The paper was critically read by all the authors and approved for publication.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par51">Ethics committees at the Institute of Nutrition and Food Technology (INTA) of the University of Chile and the Ministry of Health (Government of Chile) approved the study. All participants provided full written informed consent before being enrolled in the study.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par52">Consent for publication was obtained from all patients.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par53">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p id="Par54">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucock</surname><given-names>M</given-names></name></person-group><article-title>Folic acid: nutritional biochemistry, molecular biology, and role in disease processes</article-title><source>Mol Genet Metab</source><year>2000</year><volume>71</volume><fpage>121</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1006/mgme.2000.3027</pub-id><?supplied-pmid 11001804?><pub-id pub-id-type="pmid">11001804</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertrampf</surname><given-names>E</given-names></name><name><surname>Cort&#x000e9;s</surname><given-names>F</given-names></name></person-group><article-title>National food-fortification program with folic acid in Chile</article-title><source>Food Nutr Bull</source><year>2008</year><volume>29</volume><fpage>S231</fpage><lpage>S237</lpage><pub-id pub-id-type="doi">10.1177/15648265080292S128</pub-id><?supplied-pmid 18709898?><pub-id pub-id-type="pmid">18709898</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Ministry of Health (MINSAL), Chilean Government. Encuesta Nacional de Consumo Alimentario (ENCA 2009-2019). 2010. <ext-link ext-link-type="uri" xlink:href="http://web.minsal.cl/enca">http://web.minsal.cl/enca</ext-link>.</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>S</given-names></name><name><surname>de la Maza</surname><given-names>P</given-names></name><name><surname>Barrera</surname><given-names>G</given-names></name><name><surname>Gatt&#x000e1;s</surname><given-names>V</given-names></name><name><surname>Petermann</surname><given-names>M</given-names></name><name><surname>Bunout</surname><given-names>D</given-names></name></person-group><article-title>The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people</article-title><source>J Nutr</source><year>2002</year><volume>132</volume><fpage>289</fpage><lpage>291</lpage><?supplied-pmid 11823592?><pub-id pub-id-type="pmid">11823592</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez</surname><given-names>H</given-names></name><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>Hertrampf</surname><given-names>E</given-names></name><name><surname>Verdugo</surname><given-names>R</given-names></name><name><surname>Lavados</surname><given-names>M</given-names></name><name><surname>Castillo</surname><given-names>JL</given-names></name><name><surname>Lera</surname><given-names>L</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name></person-group><article-title>Prevalence of vitamin B-12 deficiency in older adults</article-title><source>Rev Med Chil</source><year>2010</year><volume>138</volume><fpage>44</fpage><lpage>52</lpage><?supplied-pmid 20361150?><pub-id pub-id-type="pmid">20361150</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>C</given-names></name><name><surname>Caudill</surname><given-names>S</given-names></name><name><surname>Gunter</surname><given-names>E</given-names></name></person-group><article-title>Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and nutrition examination survey 1999&#x02013;2001</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>82</volume><fpage>442</fpage><lpage>450</lpage><?supplied-pmid 16087991?><pub-id pub-id-type="pmid">16087991</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>S</given-names></name><name><surname>Leiva</surname><given-names>L</given-names></name><name><surname>de la Maza</surname><given-names>P</given-names></name><name><surname>Gattas</surname><given-names>V</given-names></name><name><surname>Barrera</surname><given-names>G</given-names></name><name><surname>Hertrampf</surname><given-names>E</given-names></name><name><surname>Bunout</surname><given-names>D</given-names></name></person-group><article-title>Effects of a nutritional supplement fortified with vitamin B-12 on well nourished, free-living elderly subjects</article-title><source>Int J Vitam Nutr Res</source><year>2006</year><volume>76</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1024/0300-9831.76.2.95</pub-id><?supplied-pmid 16941421?><pub-id pub-id-type="pmid">16941421</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shane</surname><given-names>B</given-names></name></person-group><article-title>Folate and vitamin B12 metabolism: overview and interaction with riboflavin, vitamin B6, and polymorphisms</article-title><source>Food Nutr Bull</source><year>2008</year><volume>29</volume><issue>2 Suppl</issue><fpage>S5</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1177/15648265080292S103</pub-id><?supplied-pmid 18709878?><pub-id pub-id-type="pmid">18709878</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Ministry of Health (MINSAL), Government of Chile. Encuesta Nacional de Salud (ENS 2009-2010). 2010.<ext-link ext-link-type="uri" xlink:href="http://web.minsal.cl/portal/url/item/bcb03d7bc28b64dfe040010165012d23.pdf">http://web.minsal.cl/portal/url/item/bcb03d7bc28b64dfe040010165012d23.pdf</ext-link>.</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>MS</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Rosenberg</surname><given-names>IH</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name></person-group><article-title>Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><fpage>193</fpage><lpage>200</lpage><?supplied-pmid 17209196?><pub-id pub-id-type="pmid">17209196</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>A</given-names></name><name><surname>Verdugo</surname><given-names>R</given-names></name><name><surname>Hertrampf</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Fedosov</surname><given-names>SN</given-names></name><name><surname>Shahab-Ferdows</surname><given-names>S</given-names></name><name><surname>Sanchez</surname><given-names>H</given-names></name><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>Castillo</surname><given-names>JL</given-names></name><name><surname>Matamala</surname><given-names>JM</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name></person-group><article-title>Vitamin B-12 treatment of asymptomatic, deficient, elderly Chileans improves conductivity in myelinated peripheral nerves, but high serum folate impairs vitamin B-12 status response assessed by the combined indicator of vitamin B-12 status</article-title><source>Am J Clin Nutr</source><year>2016</year><volume>103</volume><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.3945/ajcn.115.116509</pub-id><?supplied-pmid 26607937?><pub-id pub-id-type="pmid">26607937</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernando-Herraez</surname><given-names>I</given-names></name><name><surname>Heyn</surname><given-names>H</given-names></name><name><surname>Fernandez-Callejo</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>E</given-names></name><name><surname>Fernandez-Bellon</surname><given-names>H</given-names></name><name><surname>Prado-Martinez</surname><given-names>J</given-names></name><name><surname>Sharp</surname><given-names>AJ</given-names></name><name><surname>Esteller</surname><given-names>M</given-names></name><name><surname>Marques-Bonet</surname><given-names>T</given-names></name></person-group><article-title>The interplay between DNA methylation and sequence divergence in recent human evolution</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>8204</fpage><lpage>8214</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv693</pub-id><?supplied-pmid 26170231?><pub-id pub-id-type="pmid">26170231</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Schneper</surname><given-names>LM</given-names></name><name><surname>Notterman</surname><given-names>DA</given-names></name></person-group><article-title>DNA methylation, early life environment, and health outcomes</article-title><source>Pediatr Res</source><year>2016</year><volume>79</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1038/pr.2015.193</pub-id><?supplied-pmid 26466079?><pub-id pub-id-type="pmid">26466079</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Shukla</surname><given-names>S</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Meeran</surname><given-names>SM</given-names></name></person-group><article-title>Epigenetic targets in cancer and aging: dietary and therapeutic interventions</article-title><source>Expert Opin Ther Targets</source><year>2016</year><volume>20</volume><fpage>689</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1517/14728222.2016.1132702</pub-id><?supplied-pmid 26667209?><pub-id pub-id-type="pmid">26667209</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warton</surname><given-names>K</given-names></name><name><surname>Mahon</surname><given-names>K</given-names></name><name><surname>Samimi</surname><given-names>G</given-names></name></person-group><article-title>Methylated circulating tumor DNA in blood: power in cancer prognosis and response</article-title><source>Endocr Relat Cancer</source><year>2016</year><volume>13</volume><fpage>ERC-15-0369</fpage></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Xue M, Lai SC, Wang LJ. Non-invasive DNA methylation biomarkers in colorectal cancer: a systematic review. J Dig Dis. 2015 Nov 13; doi:10.1111/1751-2980.12299. [Epub ahead of print]</mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Institute of Medicine (US): Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. A Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients, Food and Nutrition Board, Washington (DC) National Academies Press; 1998.</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>RO</given-names></name><name><surname>Bollati</surname><given-names>V</given-names></name><name><surname>Tarantini</surname><given-names>L</given-names></name><name><surname>Litonjua</surname><given-names>AA</given-names></name><name><surname>Suh</surname><given-names>HH</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><article-title>Rapid DNA methylation changes after cxposure to traffic particles</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>179</volume><fpage>572</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1164/rccm.200807-1097OC</pub-id><?supplied-pmid 19136372?><pub-id pub-id-type="pmid">19136372</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>CQ</given-names></name><name><surname>Young</surname><given-names>MR</given-names></name><name><surname>Diwan</surname><given-names>BA</given-names></name><name><surname>Cooga</surname><given-names>TP</given-names></name><name><surname>Waalkes</surname><given-names>MP</given-names></name></person-group><article-title>Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression</article-title><source>Medical Sciences</source><year>1997</year><volume>94</volume><fpage>10907</fpage><lpage>10912</lpage></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>ZY</given-names></name><name><surname>Tang</surname><given-names>LD</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Aberrant DNA methylation in hepatocellular carcinoma</article-title><source>Tumor Biol</source><year>2015</year><volume>36</volume><fpage>1487</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1007/s13277-014-2632-3</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YC</given-names></name><name><surname>Lv</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>JL</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Hong</surname><given-names>LL</given-names></name><name><surname>Zhu</surname><given-names>WY</given-names></name><name><surname>Yu</surname><given-names>QM</given-names></name><name><surname>Wang</surname><given-names>XB</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Ling</surname><given-names>ZQ</given-names></name></person-group><article-title>Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer</article-title><source>Int J Clin Exp Pathol</source><year>2014</year><volume>7</volume><fpage>1553</fpage><lpage>1562</lpage><?supplied-pmid 24817951?><pub-id pub-id-type="pmid">24817951</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuan</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><name><surname>Sun</surname><given-names>CA</given-names></name><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Lin</surname><given-names>FG</given-names></name><name><surname>Hsu</surname><given-names>CH</given-names></name><name><surname>Kan</surname><given-names>PC</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Chou</surname><given-names>Y-C</given-names></name></person-group><article-title>DNA Methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>e0123396</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0123396</pub-id><?supplied-pmid 25815725?><pub-id pub-id-type="pmid">25815725</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>SL</given-names></name><name><surname>Krarup</surname><given-names>HB</given-names></name><name><surname>Sunesen</surname><given-names>KG</given-names></name><name><surname>Pedersen</surname><given-names>IS</given-names></name><name><surname>Madsen</surname><given-names>PH</given-names></name><name><surname>Thorlacius-Ussing</surname><given-names>O</given-names></name></person-group><article-title>Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review</article-title><source>Color Dis</source><year>2016</year><volume>18</volume><issue>6</issue><fpage>549</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1111/codi.13336</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotake</surname><given-names>Y</given-names></name><name><surname>Naemura</surname><given-names>M</given-names></name><name><surname>Murasaki</surname><given-names>C</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name></person-group><article-title>Transcriptional regulation of the p16 tumor suppressor gene</article-title><source>Anticancer Res</source><year>2015</year><volume>35</volume><fpage>4397</fpage><lpage>4401</lpage><?supplied-pmid 26168478?><pub-id pub-id-type="pmid">26168478</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waki</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>G</given-names></name><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Nishizuka</surname><given-names>S</given-names></name><name><surname>Motoyama</surname><given-names>T</given-names></name></person-group><article-title>Promoter methylation status of e-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia</article-title><source>Am J Pathol</source><year>2002</year><volume>161</volume><fpage>399</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64195-8</pub-id><?supplied-pmid 12163364?><pub-id pub-id-type="pmid">12163364</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name></person-group><article-title>Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>673</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgm228</pub-id><?supplied-pmid 17942460?><pub-id pub-id-type="pmid">17942460</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelsomino</surname><given-names>F</given-names></name><name><surname>Barbolini</surname><given-names>M</given-names></name><name><surname>Spallanzani</surname><given-names>A</given-names></name><name><surname>Pugliese</surname><given-names>G</given-names></name><name><surname>Cascinu</surname><given-names>S</given-names></name></person-group><article-title>The evolving role of microsatellite instability in colorectal cancer: a review</article-title><source>Cancer Treat Rev</source><year>2016</year><volume>51</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2016.10.005</pub-id><?supplied-pmid 27838401?><pub-id pub-id-type="pmid">27838401</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lyu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Shang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name></person-group><article-title>Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review</article-title><source>Tumor Biol</source><year>2015</year><volume>36</volume><fpage>1595</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1007/s13277-014-2752-9</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>S</given-names></name><name><surname>Sanchez</surname><given-names>H</given-names></name><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>De la Maza</surname><given-names>MP</given-names></name><name><surname>Barrera</surname><given-names>G</given-names></name><name><surname>Leiva</surname><given-names>L</given-names></name><name><surname>Bunout</surname><given-names>D</given-names></name></person-group><article-title>Colon cancer in Chile before and after the start of the flour fortification program with folic acid</article-title><source>Eur J Gastroenterol Hepatol</source><year>2009</year><volume>21</volume><fpage>436</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1097/MEG.0b013e328306ccdb</pub-id><?supplied-pmid 19190501?><pub-id pub-id-type="pmid">19190501</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>H</given-names></name><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>Lera</surname><given-names>L</given-names></name><name><surname>Dangour</surname><given-names>AD</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name></person-group><article-title>Effectiveness of the National Program of complementary feeding for older adults in Chile on vitamin B12 status in older adults; secondary outcome analysis from the CENEX study (ISRCTN48153354)</article-title><source>Nutr J</source><year>2013</year><volume>12</volume><fpage>124</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-12-124</pub-id><?supplied-pmid 24016218?><pub-id pub-id-type="pmid">24016218</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health, Chile, Statiscian Department</collab></person-group><source>PACAM Report</source><year>2010</year></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname><given-names>P</given-names></name><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>Klaasen</surname><given-names>G</given-names></name></person-group><article-title>Validation of a screening test for age associated cognitive impairment, in Chile</article-title><source>Rev M&#x000e9;d Chile</source><year>2004</year><volume>132</volume><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.4067/S0034-98872004000400009</pub-id><?supplied-pmid 15382519?><pub-id pub-id-type="pmid">15382519</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>TL</given-names></name><name><surname>Keyes</surname><given-names>WR</given-names></name><name><surname>Shahab-Ferdows</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name><name><surname>Newman</surname><given-names>JW</given-names></name></person-group><article-title>Methylmalonic acid quantification in low serum volumes by UPLC&#x02013;MS/MS</article-title><source>J Chromatogr B Anal Technol Biomed Life Sci</source><year>2011</year><volume>879</volume><fpage>1502</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2011.03.039</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>MB</given-names></name><name><surname>Vahter</surname><given-names>M</given-names></name><name><surname>Concha</surname><given-names>G</given-names></name><name><surname>Broberg</surname><given-names>K</given-names></name></person-group><article-title>Low-level environmental cadmium exposure is associated with DNA hypomethylation in Argentinean women</article-title><source>Environ Health Perspect</source><year>2012</year><volume>120</volume><fpage>879</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1289/ehp.1104600</pub-id><?supplied-pmid 22382075?><pub-id pub-id-type="pmid">22382075</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>MB</given-names></name><name><surname>Vahter</surname><given-names>M</given-names></name><name><surname>Concha</surname><given-names>G</given-names></name><name><surname>Broberg</surname><given-names>K</given-names></name></person-group><article-title>Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype</article-title><source>Metallomics</source><year>2012</year><volume>4</volume><fpage>1167</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1039/c2mt20120h</pub-id><?supplied-pmid 23073540?><pub-id pub-id-type="pmid">23073540</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>LC</given-names></name><name><surname>Remack</surname><given-names>JS</given-names></name><name><surname>Brent</surname><given-names>TP</given-names></name></person-group><article-title>In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription</article-title><source>Biochim Biophys Acta</source><year>1994</year><volume>1217</volume><fpage>141</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/0167-4781(94)90027-2</pub-id><?supplied-pmid 8110828?><pub-id pub-id-type="pmid">8110828</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawachi</surname><given-names>T</given-names></name><name><surname>Soejima</surname><given-names>H</given-names></name><name><surname>Urano</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Higashimoto</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>Y</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name><name><surname>Kudo</surname><given-names>S</given-names></name><name><surname>Kitajima</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Matsuzaki</surname><given-names>H</given-names></name><name><surname>Emi</surname><given-names>M</given-names></name><name><surname>Nakabeppu</surname><given-names>Y</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Sekiguchi</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>T</given-names></name></person-group><article-title>Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>8835</fpage><lpage>8844</lpage><?supplied-pmid 14647440?><pub-id pub-id-type="pmid">14647440</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnecke</surname><given-names>PM</given-names></name><name><surname>Stirzaker</surname><given-names>C</given-names></name><name><surname>Melki</surname><given-names>JR</given-names></name><name><surname>Millar</surname><given-names>DS</given-names></name><name><surname>Paul</surname><given-names>CL</given-names></name><name><surname>Clark</surname><given-names>CJ</given-names></name></person-group><article-title>Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>4422</fpage><lpage>4426</lpage><pub-id pub-id-type="doi">10.1093/nar/25.21.4422</pub-id><?supplied-pmid 9336479?><pub-id pub-id-type="pmid">9336479</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitkumthorn</surname><given-names>N</given-names></name><name><surname>Tuangsintanakul</surname><given-names>T</given-names></name><name><surname>Rattanatanyong</surname><given-names>P</given-names></name><name><surname>Tiwawech</surname><given-names>D</given-names></name><name><surname>Mutirangura</surname><given-names>A</given-names></name></person-group><article-title>LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients</article-title><source>Clin Chim Acta</source><year>2012</year><volume>18</volume><issue>413</issue><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2012.01.024</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>M</given-names></name></person-group><article-title>Expression of various genes is controlled by DNA methylation during mammalian development</article-title><source>J Cell Biochem</source><year>2003</year><volume>88</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1002/jcb.10464</pub-id><?supplied-pmid 12616529?><pub-id pub-id-type="pmid">12616529</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nexo</surname><given-names>E</given-names></name><name><surname>Hoffmann-L&#x000fc;cke</surname><given-names>E</given-names></name></person-group><article-title>Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility</article-title><source>Am J Clin Nutr</source><year>2011</year><volume>94</volume><fpage>359S</fpage><lpage>365S</lpage><pub-id pub-id-type="doi">10.3945/ajcn.111.013458</pub-id><?supplied-pmid 21593496?><pub-id pub-id-type="pmid">21593496</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannibal</surname><given-names>L</given-names></name><name><surname>Lysne</surname><given-names>V</given-names></name><name><surname>Bj&#x000f8;rke-Monse</surname><given-names>A-L</given-names></name><name><surname>Behringer</surname><given-names>S</given-names></name><name><surname>Gr&#x000fc;nert</surname><given-names>SC</given-names></name><name><surname>Spiekerkoette</surname><given-names>U</given-names></name><name><surname>Jacobsen</surname><given-names>DW</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name></person-group><article-title>Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency</article-title><source>Front Mol Biosci</source><year>2016</year><volume>3</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.3389/fmolb.2016.00027</pub-id><?supplied-pmid 27446930?><pub-id pub-id-type="pmid">27446930</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willinek</surname><given-names>WA</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Lennarz</surname><given-names>M</given-names></name><name><surname>H&#x000f6;ller</surname><given-names>T</given-names></name><name><surname>Stumpe</surname><given-names>KO</given-names></name></person-group><article-title>High-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy subjects</article-title><source>J Hypertens</source><year>2000</year><volume>18</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1097/00004872-200018040-00011</pub-id><?supplied-pmid 10779093?><pub-id pub-id-type="pmid">10779093</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YH</given-names></name><name><surname>Tang</surname><given-names>JY</given-names></name><name><surname>Wu</surname><given-names>MJ</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Qin</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>JF</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>9</issue><fpage>e25142</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025142</pub-id><?supplied-pmid 21980387?><pub-id pub-id-type="pmid">21980387</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbing</surname><given-names>M</given-names></name><name><surname>B&#x000f8;naa</surname><given-names>KH</given-names></name><name><surname>Nyg&#x000e5;rd</surname><given-names>O</given-names></name><name><surname>Arnesen</surname><given-names>E</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><name><surname>Nordrehaug</surname><given-names>JE</given-names></name><name><surname>Rasmussen</surname><given-names>K</given-names></name><name><surname>Nj&#x000f8;lstad</surname><given-names>I</given-names></name><name><surname>Refsum</surname><given-names>H</given-names></name><name><surname>Nilsen</surname><given-names>DW</given-names></name><name><surname>Tverdal</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name></person-group><article-title>Cancer incidence and mortality after treatment with folic acid and vitamin B12</article-title><source>JAMA</source><year>2009</year><volume>302</volume><fpage>2119</fpage><lpage>2126</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1622</pub-id><?supplied-pmid 19920236?><pub-id pub-id-type="pmid">19920236</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>JB</given-names></name><name><surname>Dickstein</surname><given-names>A</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Haggarty</surname><given-names>P</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Dallal</surname><given-names>G</given-names></name><name><surname>Rosenberg</surname><given-names>IH</given-names></name></person-group><article-title>A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2007</year><volume>16</volume><fpage>1325</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-0329</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AJ</given-names></name><name><surname>Travis</surname><given-names>RC</given-names></name><name><surname>Appleby</surname><given-names>PN</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Barricarte Gurrea</surname><given-names>A</given-names></name><name><surname>Bj&#x000f8;rge</surname><given-names>T</given-names></name><name><surname>Bueno-de-Mesquita</surname><given-names>HB</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Donovan</surname><given-names>J</given-names></name><name><surname>Gislefoss</surname><given-names>R</given-names></name><name><surname>Goodman</surname><given-names>G</given-names></name><name><surname>Gunter</surname><given-names>M</given-names></name><name><surname>Hamdy</surname><given-names>FC</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>IB</given-names></name><name><surname>K&#x000fc;hn</surname><given-names>T</given-names></name><name><surname>M&#x000e4;nnist&#x000f6;</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Neuhouser</surname><given-names>ML</given-names></name><name><surname>Nyg&#x000e5;rd</surname><given-names>O</given-names></name><name><surname>Stattin</surname><given-names>P</given-names></name><name><surname>Tell</surname><given-names>GS</given-names></name><name><surname>Trichopoulou</surname><given-names>A</given-names></name><name><surname>Tumino</surname><given-names>R</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><name><surname>Ulvik</surname><given-names>A</given-names></name><name><surname>de Vogel</surname><given-names>S</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><name><surname>Weinstein</surname><given-names>SJ</given-names></name><name><surname>Key</surname><given-names>TJ</given-names></name><name><surname>Allen</surname><given-names>NE</given-names></name></person-group><article-title>Endogenous hormones, nutritional biomarkers, and prostate cancer collaborative group</article-title><source>Eur Urol</source><year>2016</year><volume>70</volume><fpage>941</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2016.03.029</pub-id><?supplied-pmid 27061263?><pub-id pub-id-type="pmid">27061263</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zsch&#x000e4;bitz</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>TY</given-names></name><name><surname>Neuhouser</surname><given-names>ML</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Ray</surname><given-names>RM</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Maneval</surname><given-names>DR</given-names></name><name><surname>Beresford</surname><given-names>SA</given-names></name><name><surname>Lane</surname><given-names>D</given-names></name><name><surname>Shikany</surname><given-names>JM</given-names></name><name><surname>Ulrich</surname><given-names>CM</given-names></name></person-group><article-title>B vitamin intakes and incidence of colorectal cancer: results from the Women&#x02019;s Health Initiative observational study cohort</article-title><source>Am J Clin Nutr</source><year>2013</year><volume>97</volume><fpage>332</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.034736</pub-id><?supplied-pmid 23255571?><pub-id pub-id-type="pmid">23255571</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Guelpen</surname><given-names>B</given-names></name><name><surname>Hultdin</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Stenling</surname><given-names>R</given-names></name><name><surname>Riboli</surname><given-names>E</given-names></name><name><surname>Winkvist</surname><given-names>A</given-names></name><name><surname>Palmqvist</surname><given-names>R</given-names></name></person-group><article-title>Low folate levels may protect against colorectal cancer</article-title><source>Gut</source><year>2006</year><volume>55</volume><fpage>1461</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1136/gut.2005.085480</pub-id><?supplied-pmid 16638790?><pub-id pub-id-type="pmid">16638790</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Juan</surname><given-names>W</given-names></name><name><surname>Sahyoun</surname><given-names>NR</given-names></name></person-group><article-title>Intake and biomarkers of folate and risk of cancer morbidity in older adults, NHANES 1999&#x02013;2002 with Medicare linkage</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>2</issue><fpage>e0148697</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0148697</pub-id><?supplied-pmid 26862893?><pub-id pub-id-type="pmid">26862893</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhavan-Niaki</surname><given-names>H</given-names></name><name><surname>Samadani</surname><given-names>AA</given-names></name></person-group><article-title>DNA methylation and cancer development: molecular mechanism</article-title><source>Cell Biochem Biophys</source><year>2013</year><volume>67</volume><fpage>501</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1007/s12013-013-9555-2</pub-id><?supplied-pmid 23508887?><pub-id pub-id-type="pmid">23508887</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Niu</surname><given-names>M</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>W</given-names></name><name><surname>Pang</surname><given-names>D</given-names></name></person-group><article-title>Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>18485</fpage><lpage>18494</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.7608</pub-id><?supplied-pmid 26918343?><pub-id pub-id-type="pmid">26918343</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Que</surname><given-names>B</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name></person-group><article-title>The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis</article-title><source>Int J Clin Exp Med</source><year>2015</year><volume>8</volume><fpage>20701</fpage><lpage>20711</lpage><?supplied-pmid 26884993?><pub-id pub-id-type="pmid">26884993</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Shuai</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer</article-title><source>Med Oncol</source><year>2012</year><volume>29</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1007/s12032-010-9805-8</pub-id><?supplied-pmid 21264540?><pub-id pub-id-type="pmid">21264540</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kok</surname><given-names>DE</given-names></name><name><surname>Dhonukshe-Rutten</surname><given-names>RA</given-names></name><name><surname>Lute</surname><given-names>C</given-names></name><name><surname>Heil</surname><given-names>SG</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>van der Velde</surname><given-names>N</given-names></name><name><surname>van Meurs</surname><given-names>JB</given-names></name><name><surname>van Schoor</surname><given-names>NM</given-names></name><name><surname>Hooiveld</surname><given-names>GJ</given-names></name><name><surname>de Groot</surname><given-names>LC</given-names></name><name><surname>Kampman</surname><given-names>E</given-names></name><name><surname>Steegenga</surname><given-names>WT</given-names></name></person-group><article-title>The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects</article-title><source>Clin Epigenetics</source><year>2015</year><volume>7</volume><fpage>121</fpage><pub-id pub-id-type="doi">10.1186/s13148-015-0154-5</pub-id><?supplied-pmid 26568774?><pub-id pub-id-type="pmid">26568774</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>BS</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><article-title>Nucleic acid modifications in regulation of gene expression</article-title><source>Cell Chem Biol</source><year>2016</year><volume>21</volume><issue>23</issue><fpage>74</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2015.11.007</pub-id></element-citation></ref></ref-list></back></article>